Results 71 to 80 of about 726,279 (98)

The Validation of a Novel, Sex-Specific LDL-Cholesterol Equation and the Friedewald, Sampson-NIH, and Extended-Martin-Hopkins Equations Against Direct Measurement in Korean Adults. [PDF]

Metabolites
Yang HS, Kim SN, Lee S, Hur M.
europepmc   +1 more source

LDL-Cholesterol-Lowering Effects of a Dietary Supplement Containing Onion and Garlic Extract Used in Healthy Volunteers. [PDF]

Nutrients
Vezza T, Guillamón E, García-García J, Baños A, Mut-Salud N, García-López JD, Gómez-Fernández GO, Rodriguez-Nogales A, Gálvez J, Fonollá J.   +9 more
europepmc   +1 more source

Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease. [PDF]

Rev Cardiovasc Med
Leiter LA, Hegele RA, Brown V, Bergeron J, Mackinnon ES, Mancini GBJ.   +5 more
europepmc   +1 more source

2024 Egyptian consensus statement on the role of non-statin therapies for LDL cholesterol lowering in different patient risk categories. [PDF]

Egypt Heart J
El Din Taha HS, Kandil H, Badran HM, Farag N, Khamis H, Nasr G, Samy M, Abdrabou M, Abuelezz M, Shaker MM.   +9 more
europepmc   +1 more source

Competing Genetic Traits and Their Influence on LDL Cholesterol Concentration in Familial Hypercholesterolemia. [PDF]

JACC Case Rep
Song C, Rosenson RS.
europepmc   +1 more source

Ferritin-based disruptor nanoparticles: A novel strategy to enhance LDL cholesterol clearance via multivalent inhibition of PCSK9-LDL receptor interaction. [PDF]

Protein Sci
Incocciati A, Cappelletti C, Masciarelli S, Liccardo F, Piacentini R, Giorgi A, Bertuccini L, De Berardis B, Fazi F, Boffi A, Bonamore A, Macone A.   +11 more
europepmc   +1 more source

MAFLD and Small Dense LDL Cholesterol: A Mechanistic Link. [PDF]

J Atheroscler Thromb
Shimabukuro M.
europepmc   +1 more source

Risk of Cardiovascular Events in Metabolically Healthy Overweight or Obese Adults: Role of LDL-Cholesterol in the Stratification of Risk. [PDF]

Diagnostics (Basel)
Palatini P, Virdis A, Masi S, Mengozzi A, Casiglia E, Tikhonoff V, Cicero AFG, Ungar A, Parati G, Rivasi G, Salvetti M, Barbagallo CM, Bombelli M, Dell'Oro R, Bruno B, Lippa L, D'Elia L, Masulli M, Verdecchia P, Reboldi G, Angeli F, Cianci R, Mallamaci F, Cirillo M, Rattazzi M, Cirillo P, Gesualdo L, Russo E, Mazza A, Giannattasio C, Maloberti A, Volpe M, Tocci G, Iaccarino G, Nazzaro P, Galletti F, Ferri C, Desideri G, Viazzi F, Pontremoli R, Muiesan ML, Grassi G, Borghi C, Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA).   +43 more
europepmc   +1 more source

The role of PCSK9 in heart failure and other cardiovascular diseases-mechanisms of action beyond its effect on LDL cholesterol. [PDF]

Heart Fail Rev
Dutka M, Zimmer K, Ćwiertnia M, Ilczak T, Bobiński R.   +4 more
europepmc   +1 more source